Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Knoxville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
PROVECTUS BIOPHARMACEUTICALS, INC. has filed 1,070 SEC EDGAR filings since 31 Mar 2000

SEC filing history

Showing 651-675 of 796 matching filings.

Per page
25
Current page
27
POS AM File 333-167906

FORM POS AM

Filing date
08 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-175578

FORM POS AM

Filing date
08 Apr 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-192992

D filing

Filing date
08 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

FORM 8-K

Filing date
28 Feb 2013
Reporting date
22 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-32172

PROVECTUS PHARMACEUTICALS, INC.

Filing date
12 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Dec 2012
Reporting date
03 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

FORM 8-K

Filing date
23 Nov 2012
Reporting date
23 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
20 Nov 2012
Reporting date
16 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-187245

D filing

Filing date
19 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-182476

FREE WRITING PROSPECTUS

Filing date
23 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

FORM 8-K

Filing date
17 Oct 2012
Reporting date
17 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-182476

FORM 424B5

Filing date
04 Sep 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-182219

D filing

Filing date
03 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-182476

EFFECT filing

Filing date
20 Jul 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Jul 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
17 Jul 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Jul 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
12 Jul 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 Jul 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-09410

PROVECTUS PHARMACEUTICALS, INC. 8-K JUNE 28, 2012

Filing date
02 Jul 2012
Reporting date
28 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jul 2012
Reporting date
28 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .